Skip to main content

ScienceDex / Researcher record

Egwuagu, Charles E

From the FY2017 NIH awards this investigator leads as contact PI. The department is the award's.

FY2017 NIH rank #4,673
  • Sustained Excellence
  • Long-Funded

NIH Funding · FY2017

$1.3M
Full award amounts, FY2017
5
Records listing this PI
#4,673
By linked amount among FY2017 PIs
2007
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2007$2,596,1495#1,730
2008$2,125,5115#2,203
2009$1,393,4205#5,332
2010$1,030,1405#7,940
2011$1,081,6805#6,384
2012$1,680,2085#3,573
2013$1,654,7445#3,422
2014$1,163,7775#5,656
2015$1,292,8205#4,999
2016$1,427,4235#4,380
2017$1,349,4115#4,673
2018$1,662,4315#3,728
2019$1,980,1505#3,210
2021$2,044,7025#3,313
2022$2,072,3925#3,418
2023$2,278,7065#2,993

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20075 records
  2. FY20085 records
  3. FY20095 records
  4. FY20105 records
  5. FY20115 records
  6. FY20125 records
  7. FY20135 records
  8. FY20145 records
  9. FY20155 records
  10. FY20165 records
  11. FY2017 · selected5 records
  12. FY20185 records
  13. FY20195 records
  14. FY20215 records
  15. FY20225 records
  16. FY20235 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Egwuagu, Charles E. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2017 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2017 award records by amount

NIH award records listing Egwuagu, Charles E as a PI. Multi-PI records show the full award amount for context.

  • 1ZIAEY000262-22ZIAContact PI
    Role of IL-12 family cytokines in human autoimmune Uveitis
    $364.9K
    award amount
  • 1ZIAEY000350-18ZIAContact PI
    Development of Immunologic therapies against uveitis
    $338.7K
    award amount
  • 1ZIAEY000315-26ZIAContact PI
    Regulation of JAK/STAT pathways in the eye
    $257.3K
    award amount
  • 1ZIAEY000372-17ZIAContact PI
    Mechanisms of immune homeostasis and regulation of intraocular inflammation
    $217.9K
    award amount
  • 1ZIAEY000280-26ZIAContact PI
    Suppressors of Cytokine Signalling (SOCS) have Neuroprotective Roles in Retina
    $170.6K
    award amount

Award organization

Organizations that administered FY2017 awards listing Egwuagu, Charles E as a PI.

FY2017 award administered by National Eye Institute ().

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2007
    First NIH Award
    National Eye Institute
  2. 2007
    $500K Cumulative Funding
  3. 2007
    $1M Cumulative Funding
  4. 2007
    $2M Cumulative Funding
  5. 2007
    Entered Top 50% Nationally
    Ranked #1730
  6. 2007
    Entered Top 25% Nationally
    Ranked #1730
  7. 2007
    Entered Top 10% Nationally
    Ranked #1730
  8. 2009
    $5M Cumulative Funding
  9. 2013
    $10M Cumulative Funding
  10. 2023
    $25M Cumulative Funding